1.01 0.04 (4.12%)

New 52W Low in past week

406.8K XNAS Volume

XNAS 24 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for Inozyme Pharma Inc

The latest disclosure was made by Matthew Winton in Inozyme Pharma Inc where a trade of 41,500 Restricted Stock Units done was reported to US exchanges on March 11, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 41,500 41,500 - - Restricted Stock Units
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 145,000 145,000 - - Stock Option (right to buy)
Sanjay Subramanian SVP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 38,500 38,500 - - Restricted Stock Units
Sanjay Subramanian SVP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 145,000 145,000 - - Stock Option (right to buy)
Douglas A. Treco Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 100,000 100,000 - - Restricted Stock Units
Douglas A. Treco Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 400,000 400,000 - - Stock Option (right to buy)
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 4.45 per share. 30 Sep 2024 1,710 4,898 - 4.5 7,610 Common Stock
Douglas A. Treco Director, CEO Grant, award, or other acquisition of securities at price $ 4.45 per share. 30 Sep 2024 1,710 22,375 - 4.5 7,610 Common Stock
Axel Bolte Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 28,000 28,000 - - Stock Option (right to buy)
Edward T. Mathers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 28,000 28,000 - - Stock Option (right to buy)
Martin William Edwards Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 28,000 28,000 - - Stock Option (right to buy)
Robert Hopfner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 28,000 28,000 - - Stock Option (right to buy)
Lynne Sullivan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 28,000 28,000 - - Stock Option (right to buy)
Sarah Bhagat Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 28,000 28,000 - - Stock Option (right to buy)
Douglas A. Treco Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2024 25,000 75,000 - - Restricted Stock Units
Douglas A. Treco Director, CEO Sale of securities on an exchange or to another person at price $ 6.94 per share. 01 Apr 2024 7,523 20,665 - 6.9 52,210 Common Stock
Douglas A. Treco Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2024 25,000 28,188 - - Common Stock
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 3.33 per share. 28 Mar 2024 3,188 3,188 - 3.3 10,616 Common Stock
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Mar 2024 175,000 175,000 - - Stock Option (right to buy)
Sanjay Subramanian SVP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Mar 2024 165,000 165,000 - - Stock Option (right to buy)
Douglas A. Treco Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Mar 2024 300,000 300,000 - - Stock Option (right to buy)
Robert Hopfner Director Purchase of securities on an exchange or from another person at price $ 4.80 per share. 01 Aug 2023 714,285 1,571,741 - 4.8 3,428,568 Common Stock
Robert Hopfner Director Purchase of securities on an exchange or from another person at price $ 4.80 per share. 01 Aug 2023 119,048 2,923,110 - 4.8 571,430 Common Stock
Edward T. Mathers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 16,000 16,000 - - Stock Option (right to buy)
Sarah Bhagat Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 16,000 16,000 - - Stock Option (right to buy)
Lynne Sullivan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 16,000 16,000 - - Stock Option (right to buy)
Axel Bolte Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 16,000 16,000 - - Stock Option (right to buy)
Robert Hopfner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 16,000 16,000 - - Stock Option (right to buy)
Martin William Edwards Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 16,000 16,000 - - Stock Option (right to buy)
Robert Hopfner Director Purchase of securities on an exchange or from another person at price $ 6.25 per share. 11 May 2023 228,702 3,661,518 - 6.3 1,429,388 Common Stock
Robert Hopfner Director Purchase of securities on an exchange or from another person at price $ 6.48 per share. 11 May 2023 219,230 3,432,816 - 6.5 1,420,610 Common Stock
Axel Bolte Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2023 100,000 100,000 - - Stock option (right to buy)
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2023 250,000 250,000 - - Stock option (right to buy)
Douglas A. Treco Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2023 800,000 800,000 - - Stock option (right to buy)
Douglas A. Treco Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2023 100,000 100,000 - - Restricted stock units
Sanjay Subramanian SVP, CFO Grant, award, or other acquisition of securities at price $ 2.21 per share. 31 Mar 2023 979 28,079 - 2.2 2,164 Common Stock
Axel Bolte Director Grant, award, or other acquisition of securities at price $ 2.21 per share. 31 Mar 2023 4,806 266,696 - 2.2 10,621 Common Stock
Robert Hopfner Director Purchase of securities on an exchange or from another person at price $ 4.54 per share. 29 Mar 2023 344,592 3,213,586 - 4.5 1,563,724 Common Stock
Robert Hopfner Director Purchase of securities on an exchange or from another person at price $ 4.16 per share. 27 Mar 2023 156,766 2,868,994 - 4.2 652,335 Common Stock
Robert Hopfner Director Purchase of securities on an exchange or from another person at price $ 3.70 per share. 27 Mar 2023 51,074 2,712,228 - 3.7 188,729 Common Stock
Sanjay Subramanian SVP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2023 135,000 135,000 - - Stock option (right to buy)
Henric Bjorn Bjarke SVP, COO Purchase of securities on an exchange or from another person at price $ 1.39 per share. 15 Dec 2022 21,500 105,441 - 1.4 29,885 Common Stock
Axel Bolte Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 2.28 per share. 30 Sep 2022 3,315 261,890 - 2.3 7,558 Common Stock
Henric Bjorn Bjarke SVP, COO Grant, award, or other acquisition of securities at price $ 2.28 per share. 30 Sep 2022 3,315 83,941 - 2.3 7,558 Common Stock
Edward T. Mathers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 9,367 9,367 - - Stock Option (right to buy)
Martin William Edwards Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 9,367 9,367 - - Stock Option (right to buy)
Robert Hopfner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 9,367 9,367 - - Stock Option (Right to Buy)
Douglas A. Treco Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 9,367 9,367 - - Stock Option (right to buy)
Lynne Sullivan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 9,367 9,367 - - Stock Option (right to buy)
Sarah Bhagat Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 9,367 9,367 - - Stock Option (right to buy)
Robert Hopfner Director Purchase of securities on an exchange or from another person at price $ 3.69 per share. 19 Apr 2022 1,070,000 2,661,154 - 3.7 3,948,300 Common Stock
Henric Bjorn Bjarke SVP, COO Purchase of securities on an exchange or from another person at price $ 3.69 per share. 19 Apr 2022 27,100 80,626 - 3.7 99,999 Common Stock
Axel Bolte Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 3.69 per share. 19 Apr 2022 67,750 258,575 - 3.7 249,998 Common Stock
Sanjay Subramanian SVP, CFO Purchase of securities on an exchange or from another person at price $ 3.69 per share. 19 Apr 2022 27,100 27,100 - 3.7 99,999 Common Stock
Sanjay Subramanian SVP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2022 180,000 180,000 - - Stock option (right to buy)
Axel Bolte Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2022 275,000 275,000 - - Stock option (right to buy)
Henric Bjorn Bjarke SVP, COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2022 115,000 115,000 - - Stock option (right to buy)
Axel Bolte Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.98 per share. 24 Jun 2021 66,788 257,613 - 1.0 65,452 Common Stock
Axel Bolte Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jun 2021 66,788 100,480 - - Stock Option (right to buy)
Axel Bolte Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 24 Jun 2021 66,788 190,825 - 0.0 7 Common Stock
Douglas A. Treco Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 9,367 9,367 - - Stock Option (right to buy)
Edward T. Mathers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 9,367 9,367 - - Stock Option (right to buy)
Martin William Edwards Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 9,367 9,367 - - Stock Option (right to buy)
Robert Hopfner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 9,367 9,367 - - Stock Option (right to buy)
Lynne Sullivan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 9,367 9,367 - - Stock Option (right to buy)
Sarah Bhagat Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 9,367 9,367 - - Stock Option (right to buy)
Stephen J. DiPalma Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2021 15,000 15,000 - - Stock option (Right to Buy)
Stephen Basso SVP Finance (PFO) Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2021 13,000 13,000 - - Stock Option (right to buy)
Steven Jungles SVP, CTO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 42,000 42,000 - - Stock Option (right to buy)
Axel Bolte Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 117,000 117,000 - - Stock option (right to buy)
Stephen Basso SVP Finance (PFO) Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 27,000 27,000 - - Stock Option (right to buy)
Henric Bjorn Bjarke SVP, COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 51,000 51,000 - - Stock option (right to buy)
Deborah Wenkert SVP, CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2021 100,000 100,000 - - Stock option (Right to Buy)
Axel Bolte Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 159,187 159,187 - - Stock Option (right to buy)
Stephen Basso SVP Finance (PFO) Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 41,794 41,794 - - Stock Option (right to buy)
Henric Bjorn Bjarke SVP, COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 51,105 51,105 - - Stock Option (right to buy)
Steven Jungles SVP, CTO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 44,315 44,315 - - Stock Option (right to buy)
Axel Bolte Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 66,788 66,788 - - Stock option (right to buy)
Pedro Huertas SVP, CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 36,074 36,074 - - Stock Option (Right to buy)
Robert Hopfner Director, Ten Percent Owner 28 Jul 2020 1,403,654 1,403,654 - - Common Stock
Robert Hopfner Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 16.00 per share. 28 Jul 2020 187,500 1,591,154 - 16 3,000,000 Common Stock
Steven Jungles See Remarks 28 Jul 2020 13,381 55,417 - - Common Stock
Steven Jungles See Remarks 28 Jul 2020 100,000 0 - - Series A Convertible Preferred Stock
Joseph Schlessinger Ten Percent Owner 28 Jul 2020 13,381 286,479 - - Common Stock
Joseph Schlessinger Ten Percent Owner 28 Jul 2020 100,000 0 - - Series A Convertible Preferred Stock
Robert Hopfner Director, Ten Percent Owner 28 Jul 2020 10,489,510 0 - - Series A-2 Convertible Preferred Stock
Axel Bolte Director, See Remarks, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2020 287,706 287,706 - - Stock Option (right to buy)
Robert Hopfner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2020 9,367 9,367 - - Stock Option (right to buy)
Martin William Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2020 9,367 9,367 - - Stock Option (right to buy)
Pedro Huertas See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2020 43,951 43,951 - - Stock Option (right to buy)
Edward T. Mathers None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2020 9,367 9,367 - - Stock Option (right to buy)
Henric Bjorn Bjarke See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2020 32,905 32,905 - - Stock Option (right to buy)
Douglas A. Treco None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2020 9,367 9,367 - - Stock Option (right to buy)
Lynne Sullivan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2020 9,367 9,367 - - Stock Option (right to buy)
Stephen Basso Senior Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2020 27,433 27,433 - - Stock Option (right to buy)
Sarah Bhagat None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2020 9,367 9,367 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures